Autolus Therapeutics Financial Report: Revenue and EPS Figures Below Estimates
Thursday, 14 March 2024, 11:02
Autolus Therapeutics Financial Report
Autolus Therapeutics recently disclosed its financial performance, revealing a GAAP EPS of -$1.20, missing estimates by $0.10, and revenue of $1.69M, falling short by $0.01M.
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.